Maxigen Biotech Inc. (TPE:1783)
Taiwan · Delayed Price · Currency is TWD 43.95
+0.35 (0.80%)
At close: Mar 27, 2026
Maxigen Biotech Market Cap
Maxigen Biotech has a market cap or net worth of 3.55 billion as of March 27, 2026. Its market cap has decreased by -24.96% in one year.
Market Cap
3.55B
Enterprise Value
2.77B
Revenue
811.56M
Ranking
n/a
PE Ratio
14.95
Stock Price
43.95
Market Cap Chart
Since December 23, 2013, Maxigen Biotech's market cap has increased from 3.53B to 3.55B, an increase of 0.60%. That is a compound annual growth rate of 0.05%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 27, 2026 | 3.55B | 2.69% |
| Dec 31, 2025 | 3.45B | -20.87% |
| Dec 31, 2024 | 4.36B | 1.40% |
| Dec 29, 2023 | 4.30B | 6.65% |
| Dec 30, 2022 | 4.04B | 0.99% |
| Dec 30, 2021 | 4.00B | 151.22% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Bioteque | 8.14B |
| Formosa Optical Technology | 5.84B |
| Pacific Hospital Supply | 5.84B |
| St.Shine Optical | 5.22B |
| SciVision Biotech | 4.86B |
| Bionime | 4.37B |
| Nang Kuang Pharmaceutical | 3.65B |
| ICARES Medicus | 3.34B |